Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Mutant NRAS has remained difficult to target in cancer. New findings suggest tha...
A growing number of physicians say that medical misinformation is interfering wi...
The HiBiT Target Cell Killing (TCK) platform, with off-the-shelf, mix-and-match ...
A more coherent approach: a peptide-mapping LC-HRMS (liquid chromatography-high ...
The PROPEL program aims to control gene expression through RNA structure, buildi...
The field of regenerative medicine is gaining momentum. Mesenchymal stem cells (...
A preclinical study in post-menopausal bone loss mouse models found that CADD522...
ProBioGen’s AGE1.CR.pIX is a stable proliferating avian cell line derived from d...
Rather than requiring genetic modification of the viral glycoprotein, G-Link use...
Sponsored content brought to you by Artificial intelligence is dramatically acce...
Yuancheng (Ryan) Lu is obsessed with aging. And with eyes. As he steps outside t...
The expanded next-generation sequencing offering from Clean Cells now covers GMP...
For nearly a decade, the Beacon platform has advanced from integrated single-cel...
BCB-276 is designed to treat diffuse intrinsic pontine glioma (DIPG) by targetin...
New financing will help Moonwalk Biosciences expand its pipeline of siRNA medici...
If you’re preparing for the Comprehensive Osteopathic Medical Licensing Examinat...